| Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran A Dorgalaleh, SER Alavi, S Tabibian, S Soori, E Moradi, T Bamedi, ... Hematology 22 (4), 224-230, 2017 | 51 | 2017 |
| Development of an integrase-based ELISA for specific diagnosis of individuals infected with HIV ZR Tehrani, K Azadmanesh, E Mostafavi, S Soori, M Azizi, A Khabiri Journal of virological methods 215, 61-66, 2015 | 11 | 2015 |
| High avidity anti-integrase antibodies discriminate recent and non-recent HIV infection: Implications for HIV incidence assay ZR Tehrani, K Azadmanesh, E Mostafavi, S Gharibzadeh, S Soori, M Azizi, ... Journal of Virological Methods 253, 5-10, 2018 | 8 | 2018 |
| Comparison of 2 methods of clot solubility testing in detection of factor XIII deficiency A Dorgalaleh, S Tabibian, V Assadollahi, M Shamsizadeh, I Zareban, ... Laboratory Medicine 47 (4), 283-285, 2016 | 6 | 2016 |
| Extensive hematoma in a patient with hereditaryhypersegmentation of neutrophils B Tavasoli, S Tabibian, M Shams, F Firoozkohi, G Majid, S Souri, ... Journal of Cellular & Molecular Anesthesia 1 (3), 109-114, 2016 | 4 | 2016 |
| Relationship between single-nucleotide polymorphisms of tumor necrosis factor alpha, interleukin-10, factor II and factor V with risk of inhibitor development in patients with … S Soori, G Dadashizadeh, A Dorgalaleh, S Tabibian, MR Keramati, ... Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current …, 2019 | 3 | 2019 |
| Diagnosis, Clinical Manifestations and Management of Rare Bleeding Disorders in Iran SER Alavi, M Jalalvand, S Tabibian, S Soori, T Bamedi, A Dorgalaleh, ... Hematology, 2016 | 1 | 2016 |
| The relationship between inhibitor development factor VIII with interleukin-10 and tumor necrosis factor alpha genotypes in hemophilia A F Zaker, S Soori, A Dorgalaleh HAEMOPHILIA 24, 73-73, 2018 | | 2018 |
| Combined deficiency of vitamin K-dependent coagulation factors and extensive hemorrhage V Niazi, S Soori, K Atarodi, MH Esmaili, P Beigi, A Dorgalaleh Int J Case Rep Images 9 (1), 1-4, 2018 | | 2018 |
| A LARGE-SCALE PROSPECTIVE COHORT STUDY ON MOLECULAR BASIS OF CONGENITAL FACTOR XIII DEFICIENCY IN IRAN A DORGALALEH, S TABIBIAN, M SHAMS, B TAVASOLI, P BEIGI, ... | | 2017 |
| SEROPREVALENCE OF TOXOPLASMA GONDII IGG AND IGM SPECIFIC ANTIBODIES IN HIV INFECTED PATIENTS IN IRAN P BEYGI, S SOORI, KA BAIRAMI, M MOLLAEI | | 2017 |
| GENETIC RISK FACTORS FOR INHIBITOR DEVELOPMENT IN PATIENTS WITH HEMOPHILIA AND RARE BLEEDING DISORDERS S SOORI, A DORGALALEH, P BEIGI, M MOLLAEI | | 2017 |
| 268 Evaluation of 2 Batched Pretreatment Systems for the Measurement of Whole Blood Tacrolimus on the ARCHITECT Immunoassay Analyzer Sami Albeiroti, Michael O. Alberti, Vincent … LM Murer, SJ Pirruccello, SA Koepsell, H Turkon, B Toprak, H Yalcin, ... | | 2016 |
| Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders S Soori | | |
Morteza ShamsizadehPhD Student, School of Nursing, University of Pittsburgh在 pitt.edu 的电子邮件经过验证
Morteza ShamsizadehPhD Student, School of Nursing, University of Pittsburgh在 pitt.edu 的电子邮件经过验证